Latest US Biotech Contracts & Bids

This is a presolicitation notice for procuring a national preparedness stockpile of enzymatic debridement products for treating severe burn injuries. The notice outlines the need for a vendor-managed inventory (VMI) system to maintain a deployable cache of products. The anticipated period of performance for any resultant contracts will be up to 120 months with an initial base period of 120 months. All respondents must be registered in the System for Award Management (SAM). Further details and requirements will be described in the solicitation. The notice also mentions the possibility of developing a more effective, room temperature stable formulation, enhanced efficacy, and exploring the potential for its use on blast trauma wounds.

This special notice provides information about the forthcoming Network of Optimal Dynamic Energy Signatures Nodes program, a 39-month program with a 12-month Phase 1, a 15-month Phase 2 option period, and a 12-month Phase 3 option period. The program aims to develop computational models to predict protein functions based on protein folding, binding, and allosteric interactions. The solicitation will be available at www. ***. *. * parties should register on www. ***. *. * for future updates. This notice is not a formal solicitation, and no submissions will be accepted.

This notice is for a commercial solutions opening (CSO) for human capital services, training, education, and human resources supporting the Air Education and Training Command (AETC). Offerors are invited to submit white papers with strategic sourcing solutions for human capital services, as specified in individual areas of interest (AOIs). Submission deadlines are listed in the respective AOIs. The government may consider other NAICS codes applicable to specific AOIs. The CSO is open, and the government seeks commercial solutions to meet various objectives. AOIs will define specific needs and provide a point of contact (POC). The process involves two or three phases: phase I white paper submissions, phase II pitch sessions (if applicable), and phase III proposals. Evaluation criteria are outlined in attachment 4. Unsolicited proposals not aligned to an AOI will not be accepted. The government will not reimburse offerors for proposal submission costs. Participation by foreign entities is prohibited at the prime level. Subcontracting arrangements will be handled in accordance with the international traffic and arms regulation. Foreign national participation will be limited to public domain information only. Proprietary information may be shared with advisors, but only under an NDA. Proposals from companies providing support to 338 ESS may be discharged without evaluation if an organizational conflict of interest exists. Written, post-award debriefings will be conducted upon request, and only in accordance with FAR **** furnished property (GFP) is not anticipated to be made available under any resulting contract or agreement. Base support will be determined for each award for testing, validation, and demonstration. Specific formatting instructions for each price proposal will be specific in each AOI. Offerors must be registered in the System for Award Management (SAM) at www. ***. *. *, be considered responsible, have a satisfactory performance record, and otherwise be eligible for award based on federal law and regulation. The contracting officer cannot award a contract unless the successful offeror has updated the FAR **** representation in SAM to account for the update to the provision published in October 2020. In accordance with DFARS ****, the contracting officer cannot award a contract unless the successful offeror has a current NIST SP **** DoD assessment completed and posted in the Supplier Performance Risk System (SPRS). See DFARS **** and DFARS **** for more information regarding the requirements.

This is a solicitation for parties interested in participating in projects related to medical countermeasures development. The program will be carried out under a participant basic agreement (PBA). Interested entities must submit an email requesting participation, demonstrating technical relevancy and experience in developing medical countermeasures. The government is prohibited from soliciting and awarding actions to contractors with a history of criminal, fraudulent, or seriously improper conduct. Prospective vendors must be registered in the System for Award Management (SAM) database prior to submitting an invoice and through final payment of any agreement. Vendors must review and update their information in the SAM database annually to remain registered. This notification is for planning purposes only and does not constitute a commitment by the government.

This is a notice of intent to award a fixed-price purchase order to Olink Proteomics Inc. for reagents for the Olink Signature Q100 system. The acquisition is being conducted under FAR Part 13 simplified acquisition procedures. Interested parties may submit a capability statement. Comments must be submitted electronically to the attention of Tasha Lowe, contract specialist, by June 20, 2025, 12:45 PM EST.